Company / Net Income
Nuvalent, Inc. Net Income History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$425.4M
FY2025
5-year range
-$425.4M / -$46.3M
FY2021-FY2025
Trend
-63.1%
vs FY2024
Sector context
#196 of 216
Health Care
What the data says
Among 216 Health Care companies, Nuvalent, Inc. is in the bottom 9% for net income. Net Income has declined for 5 consecutive years, from -$15M in FY2020 to -$425M in FY2025.
Based on SEC 10-K filings.
-$425M in FY2025.
Declined from -$126M to -$425M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 216This company -$425.4M Sector average $454.3M
▼
-193.6% below sector average
Key checks
Key Insights
- Nuvalent, Inc.'s net income has declined for 5 consecutive years.
- In FY2025, net income decreased 63.1% year-over-year.
- Ranks #196 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.94 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$425.4M | -63.1% |
| FY2024 | -$260.8M | -106.6% |
| FY2023 | -$126.2M | -54.2% |
| FY2022 | -$81.9M | -76.6% |
| FY2021 | -$46.3M | -218.3% |
| FY2020 | -$14.6M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026